Achieve Life Sciences, Inc. Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
Achieve Life Sciences, Inc. (ACHV) had Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance of 2.38 million shares as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance · last filed 2013-11-07
- 2013-09-30: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 2.38M shares.
| Period end | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance |
|---|---|
| 2013-09-30 | 2.38M shares 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |